These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8123971)

  • 1. The GUSTO trial: is the open-artery hypothesis proven?
    Stringer KA; Lindenfeld J
    Ann Pharmacother; 1994 Jan; 28(1):97-8. PubMed ID: 8123971
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. tPA fast by GUSTO.
    Horton R
    Lancet; 1993 May; 341(8854):1188. PubMed ID: 8098084
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombolytic therapy for myocardial infarction: a perspective of clinical trialists. The GUSTO Investigators.
    Califf RM; Topol EJ
    Clin Cardiol; 1992 Mar; 15(3):143-4. PubMed ID: 1551260
    [No Abstract]   [Full Text] [Related]  

  • 5. GUSTO (Global Utilization of Streptokinase and Tissue plasminogen activator in Occluded arteries): logic wins at last.
    Bassand JP
    Eur Heart J; 1994 Jan; 15(1):2-4. PubMed ID: 8174579
    [No Abstract]   [Full Text] [Related]  

  • 6. Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
    Van de Werf F; Topol EJ; Lee KL; Woodlief LH; Granger CB; Armstrong PW; Barbash GI; Hampton JR; Guerci A; Simes RJ
    JAMA; 1995 May 24-31; 273(20):1586-91. PubMed ID: 7745771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GUSTO, TIMI and the case for rapid reperfusion.
    Cannon CP; Braunwald E
    Acta Cardiol; 1994; 49(1):1-8. PubMed ID: 8184639
    [No Abstract]   [Full Text] [Related]  

  • 8. Is survival in acute myocardial infarction related to thrombolytic efficacy or the open-artery hypothesis? A controversy to be investigated with GUSTO.
    Bates ER
    Chest; 1992 Apr; 101(4 Suppl):140S-150S. PubMed ID: 1555479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Rescue" thrombolysis with intracoronary tissue plasminogen activator for failed intravenous thrombolysis with streptokinase for acute myocardial infarction.
    White HD; Cross DB; Williams BF; Norris RM; Woo KS; Hamer AW; Elliott JM; Ormiston JA
    Am J Cardiol; 1995 Jan; 75(2):172-4. PubMed ID: 7810496
    [No Abstract]   [Full Text] [Related]  

  • 10. Early patency in acute myocardial infarction.
    Belenkie I
    Can J Cardiol; 1993 Mar; 9(2):149-51. PubMed ID: 8490781
    [No Abstract]   [Full Text] [Related]  

  • 11. GISSI-2 and the heparin controversy.
    White HD
    Lancet; 1990 Aug; 336(8710):297-8. PubMed ID: 1973983
    [No Abstract]   [Full Text] [Related]  

  • 12. Holding GUSTO up to the light. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
    Lee KL; Califf RM; Simes J; Van de Werf F; Topol EJ
    Ann Intern Med; 1994 May; 120(10):876-81; discussion 882-5. PubMed ID: 8154647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Issues raised by GUSTO.
    White H
    Aust N Z J Med; 1993 Dec; 23(6):739-41. PubMed ID: 8141715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breaking the thrombolytic gridlock: insights from the GUSTO trial.
    Topol EJ
    Cleve Clin J Med; 1993; 60(6):445-7. PubMed ID: 8287504
    [No Abstract]   [Full Text] [Related]  

  • 15. The GUSTO trial: background and baseline characteristics.
    Aylward P
    Aust N Z J Med; 1993 Dec; 23(6):728-31; discussion 735-6. PubMed ID: 8141712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of acute myocardial infarction in the 1990s.
    Flores ED; Lange RA; Cigarroa RG; Hillis LD
    Am J Med Sci; 1990 Jun; 299(6):415-24. PubMed ID: 2113353
    [No Abstract]   [Full Text] [Related]  

  • 17. Coronary thrombolysis: round two and beyond.
    Wilcox RG
    Br Heart J; 1991 Apr; 65(4):175-6. PubMed ID: 1903042
    [No Abstract]   [Full Text] [Related]  

  • 18. Which thrombolytic agent should one choose?
    Topol EJ
    Prog Cardiovasc Dis; 1991; 34(3):165-78. PubMed ID: 1947122
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical trials and decisions for thrombolytic therapy in patients with acute myocardial infarction.
    Conti CR
    Clin Cardiol; 1990 May; 13(5):307-8. PubMed ID: 2112073
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombolytic therapy for myocardial infarction: the problem, the promise and the price.
    Waters DD; Wiseman A
    CMAJ; 1988 Apr; 138(7):598-601. PubMed ID: 3128395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.